These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26272714)

  • 1. Enhanced elimination of dabigatran: Identifying the appropriate patient for the use of continuous venovenous hemodialysis instead of intermittent hemodialysis-A simulation analysis.
    Liesenfeld KH; Gruenenfelder F; Clemens A
    J Clin Pharmacol; 2016 May; 56(5):597-608. PubMed ID: 26272714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran.
    Bouchard J; Ghannoum M; Bernier-Jean A; Williamson D; Kershaw G; Weatherburn C; Eris JM; Tran H; Patel JP; Roberts DM
    Clin Toxicol (Phila); 2015 Mar; 53(3):156-63. PubMed ID: 25661675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacometric characterization of dabigatran hemodialysis.
    Liesenfeld KH; Staab A; Härtter S; Formella S; Clemens A; Lehr T
    Clin Pharmacokinet; 2013 Jun; 52(6):453-62. PubMed ID: 23529813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of dabigatran-induced bleeding with continuous venovenous hemodialysis.
    Paul S; Hamouda D; Prashar R; Mbaso C; Khan A; Ali A; Shah S; Assaly R
    Int J Hematol; 2015 Jun; 101(6):594-7. PubMed ID: 25633777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent hemodialysis is superior to continuous veno-venous hemodialysis/hemodiafiltration to eliminate methanol and formate during treatment for methanol poisoning.
    Zakharov S; Pelclova D; Navratil T; Belacek J; Kurcova I; Komzak O; Salek T; Latta J; Turek R; Bocek R; Kucera C; Hubacek JA; Fenclova Z; Petrik V; Cermak M; Hovda KE
    Kidney Int; 2014 Jul; 86(1):199-207. PubMed ID: 24621917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodialysis for the treatment of pulmonary hemorrhage from dabigatran overdose.
    Chen BC; Sheth NR; Dadzie KA; Smith SW; Nelson LS; Hoffman RS; Winchester JF
    Am J Kidney Dis; 2013 Sep; 62(3):591-4. PubMed ID: 23597859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective Removal of Dabigatran by Idarucizumab or Hemodialysis: A Physiologically Based Pharmacokinetic Modeling Analysis.
    Fuhr LM; Hanke N; Meibohm B; Lehr T
    Clin Pharmacokinet; 2020 Jun; 59(6):809-825. PubMed ID: 32020532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearance of levofloxacin by an in vitro model of continuous venovenous hemodialysis (CVVHD).
    Siewert S; Drewelow B; Mueller SC
    Int J Artif Organs; 2007 Oct; 30(10):889-95. PubMed ID: 17992649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Removal of Dabigatran Is Superior by Sustained Low Efficient Dialysis (SLED) Compared to Intermittent Hemodialysis.
    Artunc F; Muehlbacher T; Baumann D; Birschmann I; Kuhn J; Heyne N; Peter A
    Blood Purif; 2015; 39(4):331-2. PubMed ID: 25998505
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of continuous veno-venous haemodiafiltration therapy in dabigatran overdose.
    Chiew AL; Khamoudes D; Chan BS
    Clin Toxicol (Phila); 2014 Apr; 52(4):283-7. PubMed ID: 24666338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF.
    Augustine JJ; Sandy D; Seifert TH; Paganini EP
    Am J Kidney Dis; 2004 Dec; 44(6):1000-7. PubMed ID: 15558520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of dabigatran plasma concentrations by calibrated thrombin clotting time in comparison to LC-MS/MS in human volunteers on dialysis.
    Schmohl M; Gansser D; Moschetti V; Stangier J
    Thromb Res; 2015 Mar; 135(3):532-6. PubMed ID: 25600440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective elimination of dabigatran by haemodialysis. A phase I single-centre study in patients with end-stage renal disease.
    Khadzhynov D; Wagner F; Formella S; Wiegert E; Moschetti V; Slowinski T; Neumayer HH; Liesenfeld KH; Lehr T; Härtter S; Friedman J; Peters H; Clemens A
    Thromb Haemost; 2013 Apr; 109(4):596-605. PubMed ID: 23389759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced elimination of dabigatran through extracorporeal methods.
    Awad NI; Brunetti L; Juurlink DN
    J Med Toxicol; 2015 Mar; 11(1):85-95. PubMed ID: 25448250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrovascular autoregulation in critically ill patients during continuous hemodialysis.
    Schramm P; Closhen D; Wojciechowski J; Berres M; Klein KU; Bodenstein M; Werner C; Engelhard K
    Can J Anaesth; 2013 Jun; 60(6):564-9. PubMed ID: 23536386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Extracorporeal Techniques in the Removal of Dabigatran.
    Muddana N; Thuyanh C; Nayer A; Nashar K; Ortega LM
    Am J Ther; 2016; 23(2):e485-8. PubMed ID: 24987943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of continuous renal replacement therapy (CRRT) and intermittent haemodialysis (IHD) in the treatment of dabigatran overdose. Case report].
    Vitale C; Berutti S; Montaruli B; Cosseddu D; Sivera P; Verdecchia C; Migliardi M; Marangella M
    G Ital Nefrol; 2014; 31(2):. PubMed ID: 24777926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous venovenous haemodialysis (CVVHD) and continuous peritoneal dialysis (CPD) in the acute management of 21 children with inborn errors of metabolism.
    Arbeiter AK; Kranz B; Wingen AM; Bonzel KE; Dohna-Schwake C; Hanssler L; Neudorf U; Hoyer PF; Büscher R
    Nephrol Dial Transplant; 2010 Apr; 25(4):1257-65. PubMed ID: 19934086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Removal of dabigatran by hemodialysis.
    Chang DN; Dager WE; Chin AI
    Am J Kidney Dis; 2013 Mar; 61(3):487-9. PubMed ID: 23219111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous venovenous hemodiafiltration compared with conventional dialysis in critically ill patients with acute renal failure.
    Bellomo R; Boyce N
    ASAIO J; 1993; 39(3):M794-7. PubMed ID: 8268647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.